Literature DB >> 26200374

[Determinants of the time between breast cancer diagnosis and initiation of treatment in Brazilian women].

Giselle Coutinho Medeiros1, Anke Bergmann1, Suzana Sales de Aguiar1, Luiz Claudio Santos Thuler1.   

Abstract

This study aimed to analyze the time elapsed between breast cancer diagnosis and initiation of treatment in woman treated from 2000 to 2011 in the Brazilian public health system and to identify factors associated with delayed onset of treatment. This retrospective cohort study included 137,593 women diagnosed in 239 hospitals in Brazil from 2000 to 2011. In 63.1% of cases the time between diagnosis and treatment was 60 days. Delayed treatment was associated with nonwhite skin color (OR = 1.18; 95%CI: 1.13-1.23), single marital status (OR = 1.05; 95%CI: 1.01-1.09), less than eight years of schooling (OR = 1.13; 95%CI: 1.08-1.18), early-stage disease (OR = 1.27; 95%CI: 1.22-1.32), treatment from 2006 to 2011 (OR = 1.54; 95%CI: 1.47-1.60), and patients in the public health system (OR = 1.19; 95%CI: 1.13-1.25). Stratified analysis showed variability of factors between regions of Brazil. The identification of factors associated with delayed initiation of breast cancer treatment can support the development of interventions targeted to specific population groups.

Entities:  

Mesh:

Year:  2015        PMID: 26200374     DOI: 10.1590/0102-311X00048514

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  6 in total

1.  10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study.

Authors:  Isabela Campeti Cuoghi; Mariana Furlani da Silva Soares; Gustavo Motta Cabello Dos Santos; Francisco José Candido Dos-Reis; Omero Benedicto Poli-Neto; Jurandyr Moreira de Andrade; Priscila Longhin Bosquesi; Leonardo Fleury Orlandini; Daniel Guimarães Tiezzi
Journal:  J Glob Health       Date:  2022-10-14       Impact factor: 7.664

2.  Comparison of the performance of four staging systems in determining the prognosis of breast cancer among women undergoing neoadjuvant chemotherapy.

Authors:  Isabella Cristina Santos Soares; Marcelo Adeodato Bello; Anke Bergmann; Luiz Claudio Santos Thuler
Journal:  Breast Cancer Res Treat       Date:  2021-01-08       Impact factor: 4.872

3.  Patient Navigation to Improve Access to Breast Cancer Care in Brazil.

Authors:  Alexandra Bukowski; Sandra Gioia; Yanin Chavarri-Guerra; Enrique Soto-Perez-de-Celis; Jessica St Louis; Eduardo Paulino; Angelica Nogueira-Rodrigues; Paul E Goss
Journal:  J Glob Oncol       Date:  2016-11-30

Review 4.  Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies.

Authors:  Carlos Barrios; Ruffo Freitas-Junior; Sandro Martins; Jose Bines; Maria Del Pilar Estevez-Diz; Maira Caleffi
Journal:  JCO Glob Oncol       Date:  2021-04

5.  Availability of Diagnostic Services and their Impact on Patient Flow in Two Brazilian Referral Centres of Breast Cancer Treatment.

Authors:  Tácila Thamires de Melo Santos; Lorena Sofia Dos Santos Andrade; Milena Edite Case de Oliveira; Kedma Anne Lima Gomes; Tiago Almeida de Oliveira; Mathias Weller
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01

6.  Outcome of Patients With Breast Cancer Treated in a Private Health Care Institution in Brazil.

Authors:  Alexandre Boukai; Aline C Gonçalves; Monica Padoan; Perla Andrade; Natalia Carvalho; Flavio Lemos; Thamires Almeida; Jonas Salem; Maria F D Gauí; Nelson Teich; Luiz H Araujo
Journal:  J Glob Oncol       Date:  2018-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.